Member Info for WeTookPelham

Also as a by side ...As per that PDF, and comments elsewhere, it seems like they are "finally" embracing, promoting and pushing the virtues of the "off the shelf" approach Vs. personalised.

Better late than never I guess.

Scancell

https://scancell.co.uk

PDF

"Cancer Vaccines Improve Their Aim"

Can't post the link but if you do a search for it + "Scancell".

...by chilltime over on the other side, worth a read IMO.

@scinv

Why did the 2023 RNS specifically mention a poster but today's RNS and 2024 mention presentations?

2023:

https://www.lse.co.uk/rns/SCLP/modify-phase-12-poster-presentation-at-aacr-2023-5gpjr6hnuw2yp3u.html

2024:

https://www.lse.co.uk/rns/SCLP/scancell-to-present-at-2024-aacr-annual-meeting-rtngire4tyo6xcg.html

Also, as mentioned by Chester, where does it say poster in today's?

RE website, didn't think my point would start a heated debate!

To be honest I've not fully tested the navigation, but yes perhaps maybe certain things are not as intuitive as before.

But...moonparty made the point I should have made originally i.e. "So when interested parties follow up and do due diligence they are encouraged."

So that more professional/corporate look comes across to those that matter, IMO. And as C11 alluded too, it didn't look very slick before.

When did this happen? Another evolution it seems? Looking very professional/serious now IMO.

?

Only three trades showing mind.

...thank you very much.

Crustypete? More like CursedPete ☠️😉😁

Well, hopefully 3rd time lucky 🤞

Spoke too soon, 175k sell trade. But why didn't buys of similar sizes in the last couple of weeks have the equivalent effect on the long side?

Down on virtually no volume?

Someone else mentioned this recently, it takes basically nothing to push the SP down, but to go up it needs lots of volume/buying.

@lofas - lol 😄

How many conference/presentations is that now?

Interesting (?), getting quoted 8.9p for anything over £5000 ATM.

... Hopefully starting as we mean to go on.

Broken record I know but the big one for me was the somewhat mysterious attendance at JP healthcare 2025, with both the CEO and chief deal maker invited. Who did they speak to, what conversations were had... we can only wonder.

"Invitation-Only:

Access to the conference is restricted to clients of J.P. Morgan and is by invitation only. "

I don't recall Scancell attending/presenting at so many consecutive conferences?

"From 17-19 March, our Head of Business Development, @Mandeep Sehmi, will be on the ground in Milan, IT to connect with other hashtag#biotech leaders, business development teams, investors and other industry leaders at hashtag#BioEuropeSpring.

This hashtag#conference offers a valuable opportunity to discuss our cutting-edge DNA hashtag#CancerVaccine approach, which has the potential to address significant unmet need in hard-to-treat cancers. With Phase 2 data readouts from our ongoing SCOPE trial in advanced hashtag#melanoma expected in 2025, we are well positioned to advance new therapies in cancer care.

If you are attending hashtag#BioEuropeSpring and would like to learn more, reach out to Mandeep or contact commercial.enquiries@scancell.co.uk to connect.

hashtag#Immunotherapy hashtag#ImmunoOncology hashtag#CancerVaccines hashtag#BioEurope"

@Burble I'm hoping it's because they are rushed off their feet with other more pressing matters?

Thanks CW and of course Marcusl2.

I particularly liked inans response to the article

"...As the competition Disappears one by one ...."